I would like to clarify two matters; as there is confusion in the public domain, exports of vaccines are permitted to all countries and a joint public statement clearing up any recent miscommunication with regards to Bharat Biotech will be made. Bangladesh has signed a deal with Serum Institute of India for 30 million doses of the Oxford-AstraZeneca vaccine. According to the contract, Serum Institute will send five million doses a month. Beximco Pharma is the 'exclusive distributor' of the vaccine under the government's agreement to purchase the drug produced by Serum Institute. On Monday, its MD Nazmul Hassan said Bangladesh will get the vaccine 'within the stipulated time', adding there had been no indication of a delay on the part of Serum Institute.

Source: bd News24 January 05, 2021 08:03 UTC